Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Target Sequencing of TNFSF14 gene

PROVIDER: PRJEB32114 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	TNFSF14_2SNPS_EVAsubmission_Jan2019.vcf.gz	Vcf
	TNFSF14_2SNPS_EVAsubmission_Jan2019.vcf.gz.tbi	Vcf

Items per page:

1 - 2 of 2

Similar Datasets

Study on the Correlation Between Gene Mutation and TCM Syndrome Types in Metastatic Colorectal Cancer

Project description:To explore the correlation between gene mutations of metastatic colorectal cancer and TCM syndrome types based on Second-generation sequencing technology.

| 2360178 | ecrin-mdr-crc

The combination human 13 gene mutation Detection kit (reversible terminal termination sequencing) complements the clinical trial

Project description:Interventions: Gold Standard:Comparison methods :(1) comparison of similar kits;(2) Sequencing method;Index test:Human 13 gene mutation Combination Detection Kit (reversible terminal termination sequencing method) Primary outcome(s): Lung and gastrointestinal tumor genes Study Design: Sequential

| 2696826 | ecrin-mdr-crc

Clinical validation study of RAKSET-B, a multiple detection kit for BRAF and RAS gene mutations in colorectal cancer

Project description:Primary outcome(s): BRAF gene mutation* - Overall concordance rate, positive concordance rate, and negative concordance rate of BRAF gene mutations between standard genetic testing such as sanger sequencing and RASKET-B kit RAS gene mutation** - Overall concordance rate, positive concordance rate, and negative concordance rate of RAS gene mutations between MEBGEN RASKET KIT (an established in vitro diagnostic (IVD) kit for detecting RAS mutations) and RASKET-B kit *BRAF gene mutation codon 600 (p.V600E) **RAS gene mutation codon 12, 13, 59, 61, 117, 146

| 2637999 | ecrin-mdr-crc

Analysis of bacteremia after endoscopic submucosal dissection of the colon using molecular biological technique.

Project description:Interventions: Analysis of bacteremia after ESD of the colon. Primary outcome(s): Identification of bacteremia after ESD testing blood culture and 16SrRNA gene sequencing. Study Design: Single arm Non-randomized

| 2623655 | ecrin-mdr-crc

Study of Gut Microbiome and Colorectal Tumors

Project description:Gut microbiota were assessed in 540 colonoscopy-screened adults by 16S rRNA gene sequencing of stool samples. Investigators compared gut microbiota diversity, overall composition, and normalized taxon abundance among these groups.

| 2255499 | ecrin-mdr-crc

E-GEOD-66301

Project description:Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis

2025-01-24 | E-GEOD-66301 | ExpressionAtlas

E-MTAB-3919

Project description:Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression

2015-09-24 | E-MTAB-3919 | ExpressionAtlas

Dtg

Project description:Drosophila melanogaster Dtg, Dpp target gene, is expressed in 2 baseline experiment(s);

| FBgn0038071 | ExpressionAtlas

Dtg

Project description:Drosophila melanogaster Dtg, Dpp target gene, is differentially expressed in 19 experiment(s);

| FBgn0038071 | ExpressionAtlas

Proteogenomic Landscape and Clinical Characterization of GH-Producing Pituitary Adenoma

Project description:Gene alteration analysis on 121 GH-producing pituitary adenomas and non-target proteomics analysis with RNA sequencing analysis on 45 non-functioning pituitary adenomas (NFPAs) and 60 growth hormone (GH)-producing pituitary adenomas were performed, and integrated these results with the clinical characteristics of acromegaly. We attempted to identify key players involved in shaping the clinical features of acromegaly, especially those related to treatment efficacy. This project revealed the importance of GNAS mutations in terms of clinical and biochemical characteristics and identified novel molecules that may be involved in the responsiveness to medical treatment.

2022-11-24 | PXD036604 | JPOST Repository

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data